Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres

Journal of Microencapsulation

Volumn 27, Issue 2, 2010, Pages 178-186

  Zhao, Kai ^a,b   Li, Guo Xin ^b   Jin, Yuan Yuan ^a,b   Wei, Hai Xia ^a,b   Sun, Qing Shen ^a   Huang, Ting Ting ^a,b   Wang, Yun Feng ^b   Tong, Guang Zhi ^b  

^a HEILONGJIANG UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Cytotoxicity; Emulsion evaporation method; Immunology; Microsphere; PLGA; Swine influenza DNA vaccine

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE; MICROSPHERE; PLASMID DNA; POLYGLACTIN; VIRUS DNA; DNA; EMULSION; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BIOLOGICAL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; EMBRYO; EVAPORATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROEMULSION; MICROENCAPSULATION; MOUSE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; SWINE INFLUENZA VIRUS; ADMINISTRATION AND DOSAGE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG FORMULATION; EMULSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE; ORTHOMYXOVIRIDAE INFECTIONS; PLASMID; PROCEDURES; SWINE; SWINE DISEASES; VETERINARY;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DNA; DRUG COMPOUNDING; EMULSIONS; FEMALE; LACTIC ACID; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICROSPHERES; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; POLYGLYCOLIC ACID; SWINE; SWINE DISEASES; TRANSFECTION; VACCINES, DNA;

EID: 77149132443     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040903059239     Document Type: Article

References (52)

1. Capan Y, Woo BH, Gebrekidan S, Ahmed S, Delucap P. 1999. Influence of formulation parameters on the characteristics of poly(D,L-lactide-coglycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. J Contr Rel 60:279-286.
2. Charley B, Riffault S, Van Reeth K. 2006. Porcine innate and adaptative immune responses to influenza and coronavirus infections. Ann NY Acad Sci 1081:130-136.
3. Chen Y, Xin XG, Yang HL, Li T, Li HY, Qiao CL, et al. 2007. Establishment of an indirect ELISA for detection of antibodies against swine influenza virus. Chin J Prev Vet Med 29:308-311.
4. Chen YJ, Xu XY, Zhou JP. 2007. Research advance in PLGA microspheres. J Chin Pharm Uni 38:186-189.
5. Cohen S, Chen L, Apte RN. 1995. Controlled release of peptides and proteins from biodegradable polyester microspheres: An approach for treating infectious disease and malignancies. React Polym 25:177-187.
6. Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B, O'Hagan D, et al. 2000. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 7:2105-2112.
7. Dhama K, Mahendran M, Gupta PK, Rai A. 2008. DNA vaccines and their applications in veterinary practice: Current perspectives. Vet Res Commun 32:341-356.
8. Donnelly JJ, Wahren B, Liu MA. 2005. DNA vaccines: Progress and challenges. J Immunol 175:633-639.
9. Dubensky TW, Liu MA, Ulmer JB. 2000. Delivery systems for gene-based vaccines. Mol Med 6:723-732.
10. Forde GM. 2005. Rapid-response vaccines-does DNA offer a solution? Nat Biotechnol 23:1059-1062.
11. Gray GC, Baker WS. 2007. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther 82:638-641.
12. He XW, Wang F, Jiang L, Li J, Liu SK, Xiao ZY, et al. 2005. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J Gen Virol 86:601-610.
13. Hou F. Apr. 2007. Ectopic intramuscular expression of Ghrelin and GRF gene leads to mouse body weight gain. Masters Degree Thesis. China: Department of Biochemistry and Molecular Biology, Jilin University. p 51.
14. Hyejung M, Tae GP. 2008. Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method. Eur J Pharm Biopharm 68:105-111.
15. Jae-Hyung J, Lonnie DS. 2006. Intramuscular delivery of DNA releasing microspheres: Microsphere properties and transgene expression. J Contr Rel 112:120-128.
16. Jin HL, Li YJ, Ma ZH, Zhang FC, Xie QG, Gu DF, et al. 2004. Effect of chemical adjuvants on DNA vaccination. Vaccine 22:2925-2935.
17. Kavanagh OV, Earley B, Murray M, Foster CJ, Adair BM. 2003. Antigenspecific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly D, L-lactide-co-glycolide microspheres. Vaccine 21:4472-4480.
18. Kim SY, Doh HJ, Ahn JS, Ha YJ, Jang MH, Chung SI, et al. 1999. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly D,L-lactide-co-glycolide microparticles. Vaccine 17:607-616.
19. Kothalawala H, Toussaint MJM, Gruys E. 2006. An overview of swine influenza. Vet Q 28:45-53.
20. Laddy DJ, Weiner DB. 2006. From plasmids to protection: A review of DNA vaccines against infectious diseases. Int Rev Immunol 25:99-123.
21. Larsen DL, Karasin A, Olsen CW. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killedvirus vaccine boosting. Vaccine 2001;19(20-22):2842-2853
22. Lee JH, Gramer MR, Joo HS. 2007. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant. Can J Vet Res 71:207-212.
23. Li GX, Qiu HJ, Han CG, Han LX, Zhou YJ, Chen Y, et al. 2006. Vaccination of plasmid DNA encoding somatostatin gene fused with GP5 gene of porcine reproductive and respiratory syndrome virus induces anti-GP5 antibodies and promotes growth performance in immunized pigs. Sci Agric Sin 5:234-240.
24. Li GX, Tian ZJ, Yu H, Jin YY, Hou SH, Zhou YJ, et al. 2008. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus. Res Vet Sci 86:406-413.
25. Liu Y, Deng X. 2002. Influence of preparation conditions on particle size and DNA-loading efficiency for poly (DL-lactic-polyethylene glycol) microspheres entrapping free DNA. J Contr Rel 83:147-155.
26. Maheshwari A, Han S, Mahato RI, Kim SW. 2002. Biodegradable polymer based interleukin-12 gene delivery: Role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity. Gene Ther 9:1075-1084.
27. Manca ML, Mourtas S, Dracopoulos V. 2008. PLGA, chitosan or chitosancoated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. Colloids Surf B Biointerfaces 62:220-231.
28. Mathew T, Mahendran M, Dhama K, Kataria JM, Kothawala H, Gruys E. 2006. Swine influenza. (Chapter VI). In: Tripathi MM, Thankam M, editors. Advances in medical and veterinary virology, immunology and epidemiology. Vol.6: Influenza and it's global public health significance. West Orange, NJ: Thajema Publishers. pp 94-111.
29. Meeusen Els NT, Walker J, Peters A, Pastoret PP, Jungersen G. 2007. Current status of veterinary vaccines. Clin Microbiol Rev 20:489-510.
30. Mok H, Park TG. 2008. Direct plasmid DNA encapsulation within PLGA microspheres by single oil-in-water emulsion method. Eur J Pharm Biopharm 68:105-111.
31. Mollenkopfa HJ, Dietrichb G, Fensterlea J, Grodea L, Diehlb KD, Knappb B, et al. 2004. Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles. Vaccine 22:2690-2695.
32. Newman KD, Elamanchili P, Kwon GS, Samuel J. 2002. Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigenpresenting cells in vivo. J Biomed Mater Res 60:480-486.
33. O'Hagan DT, Singh M. 2003. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2:269-283.
34. Pachuk CJ, Mccallus DE, Weiner DB, Satishchandran C. 2000. DNA vaccines-challenges in delivery. Curr Opin Mol Ther 2:188-198.
35. Parka IK, Kim TH, Kim SI, Park YH, Kim WJ, Akaike T, et al. 2003. Visualization of transfection of hepatocytes by galactosylated chitosan-graft-poly(ethylene glycol)/DNA complexes by confocal laser scanning microscopy. Int J Pharm 257:103-110.
36. Robertson JS, Griffiths E. 2001. Assuring the quality, safety and efficacy of DNA vaccines. Mol Biotechnol 17:143-149.
37. Rouse J, Mohamed F, van der Walle CF. 2007. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA. Int J Pharm 2:112-120.
38. Ruberti M, De Melo LK, Dos Santos SA, Brandao IT, Soares EG, Silva CL, et al. 2004. Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention. J Drug Target 12:195-203.
39. Sales-Junior PA, Guzman F, Vargas MI, Sossai S, Patarroyo VAM, González CZL, et al. 2005. Use of biodegradable PLGA microspheres as a slow release delivery system for the Boophilus microplus synthetic vaccine SBm7462. Vet Immunol Immunopathol 107:281-290.
40. Sharpe S, Hanke T, Tinsley-Bown A, Dennis M, Dowall S, McMichael A, et al. 2003. Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara. Virology 13:13-21.
41. Singh M, Kazzaz J, Ugozzoli M, Chesko J, O'Hagan DT. 2004. Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther 4:483-491.
42. Singh M, O'Hagan DT. 2002. Recent advances in vaccine adjvants. Pharm Res 19:715-720.
43. Song RJ, Liu SQ, Robert J. Adams, Kam WL. 2006. Enhancing efficacy of HIV Gag DNA vaccine by local delivery of GM-CSF in murine and macaque models. J Interferon Cytokine Res 26:380-389.
44. Sudhir PK, Karishma S, Krishnendu R. 2005. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 5:6375-6385.
45. Thacker E, Janke B. 2008. Swine influenza virus: Zoonotic potential and vaccination strategies for the control of avian and swine influenzas. J Infect Dis 197:19-24.
46. Tian ZJ, Zhou GH, Zheng BL, Qiu HJ, Ni JQ, Yang HL, et al. 2006. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Vet Immunol Immunopathol 111:211-218.
47. Tinsley-Bown AM, Fretwell R, Dowsett AB, Davis SL, Farrar GH. 2000. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Contr Rel 66:229-241.
48. Vannie P, Capua I, Le Potier MF, Mackay DK, Muylkens B, et al. 2007. Marker vaccines and the impact of their use on diagnosis and prophylactic measures. Rev Sci Tech 26:351-372.
49. Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, Garcia-Sastre A, et al. 2007. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25:7999-8009.
50. Wang D, Robinson DR, Kwon GS, Samuel J. 1999. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Contr Rel 57:9-18.
51. Wang ZR, Xu QY, Ye YQ. 2004. Research progress on preparative parameters that influence the characteristics of PLA/PLGA/PELA microspheres prepared by double emulsion method. Int J Biomed Eng 29:238-242.
52. Zhou SB, Liao XY, Li XH, Deng XM, Li HM. 2003. Poly-DL-lactide-poly (ethylene glycol) microspheres as potential vaccine delivery system. J Contr Rel 86:195-205.